You searched for "intervention"

3119 results found

JORL-HNS 2025

The 126th Annual Meeting of the Japanese Society of Otorhinolaryngology – Head and Neck Surgery (JORL-HNS 2025) was held at Pacifico Yokohama in May. The event brought experts together from across Japan and further afield. Professor Shigeharu Fujieda from University...

Empowering hearing rehabilitation professionals in Sub-Saharan Africa and Asia

The Hearing Healthcare Alliance empowers professionals across Africa and Asia through comprehensive training programmes, improving local hearing rehabilitation services. According to the World Health Organization (WHO), approximately 430 million people worldwide require rehabilitation for disabling hearing loss [1]. This number...

Parathyroid pearls

This article serves to deliver some pearls of wisdom in parathyroid surgery for the ‘low volume parathyroid surgeon’. They have been divided into those relating to the preoperative diagnosis, imaging and localisation techniques and surgical difficulties. Recognised sources of error...

Making the case for multidisciplinary ENT vasculitis clinics

How can combined ENT vasculitis clinics improve diagnosis, treatment and ongoing care for patients with AAV? This article outlines a multidisciplinary approach. Antineutrophil cytoplasmic antibody (ANCA)-associated vasculitides (AAV) are a group of rare autoimmune conditions characterised by inflammation of small-...

European funding for the tinnitus research network TINNET

Over 70 million people in Europe experience tinnitus, and for seven million it creates a debilitating condition. Severe tinnitus is often associated with depression, anxiety and insomnia, resulting in an enormous socio-economic impact [1]. It has been estimated that 13...

An update on HPV and the vaccination

In recent years, the role of HPV in the development of oropharyngeal cancers has become apparent. Hannah Fox and Vin Paleri contend that while we may not always be able to cure oropharyngeal cancers, vaccination offers our best hope for...

Hypoglossal nerve stimulation for OSA: current experience with unilateral versus bilateral systems

Hypoglossal nerve stimulation (HNS) has emerged as an established treatment option for selected patients with obstructive sleep apnoea (OSA) who are intolerant to continuous positive airway pressure (CPAP). Over the past decade, technological developments have expanded the field from unilateral...

Metformin, the magical solution!

Both noise-induced hearing loss (NIHL) and vestibular schwannomas (VSs) pose a challenge in terms of management. Metformin was suggested as a potential therapeutic drug for NIHL when the drug-target interaction data was investigated. Additionally, there are studies which demonstrate reduction...

Ida Institute joins Demant

The Ida Institute, the hearing-care pioneer, has joined Demant, the Denmark-based hearing healthcare group.

Amplifon’s $2 billion move into manufacturing: what it means for audiology

Our audiology editor Yovina Khiroya writes: Amplifon, the world’s largest hearing aid retailer, has announced a reported $2 billion acquisition of GN Hearing, the company behind ReSound, Beltone and Jabra Enhance. While headline-grabbing, the strategic implications are arguably more significant than the deal value itself.

Clinical leadership and management: developing world ENT

I have been asked to share some of the initiatives I have been involved with to address ENT-related challenges in Africa and the developing world. Developing countries constitute the majority of the world’s landmass (Figure 1), are home to >50%...

Postop follow up of oral squamous cell carcinoma: a new protocol

Oral and oropharyngeal cancers together are the sixth most common malignancy in the world, with an increasing incidence of oral squamous cell carcinoma (OSCC). The recurrence rate of OSCC is reported to be approximately 10-26%. About two-thirds of all recurrent...